Antithymic Immune Factor in Schizophrenia
作者:
G. Koliaskina,
M. Tsutsulkovskaya,
I. Domashneva,
T. Maznina,
P. Kielholz,
M. Gastpar,
W. Bunney,
O. Rafaelsen,
J. Heltberg,
A. Coppen,
H. Hippius,
B. Hoecherl,
F. Vartanian,
期刊:
Neuropsychobiology
(Karger Available online 1980)
卷期:
Volume 6,
issue 6
页码: 349-355
ISSN:0302-282X
年代: 1980
DOI:10.1159/000117781
出版商: S. Karger AG
关键词: Biological Psychiatry;Schizophrenia;Antithymic factor;International collaboration;WHO (World Health Organization)
数据来源: Karger
摘要:
Six WHO Collaborating Centre took part in the study of the antithymic activity of blood sera of patients suffering from schizophrenia. Blood serum specimens from 118 schizophrenic patients and 62 mentally healthy donors were investigated. Statistically significant differences between schizophrenic patients and the controls were found (p < 0.05). It is probable that as with other biological phenomena described in schizophrenia, antithymic activity is one of the biological factors, in combination with other factors, predisposing towards the development of the schizophrenic process.
点击下载:
PDF
(845KB)
返 回